Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BIOA compared with DRUG: revenue, margins and what each company keeps, and the suppliers and customers both name
BIOA
BioAge Labs, Inc.
Change
Mkt cap
Revenue
Revenue
DRUG
Bright Minds Biosciences Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
BIOA
BioAge Labs, Inc.
vs
DRUG
Bright Minds Biosciences Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
BIOA
0 of 4
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±59.0%
▲
+2.64%
×0.04
May 8 '26
±10.8%
▲
+0.95%
×0.08
Q1 FY26
±16.5%
▼
−13.53%
×0.82
Q3 FY25
±15.6%
▼
−2.81%
×0.18
DRUG
No earnings history for DRUG.
= implied
BIOA realized, solid
DRUG realized, hatched
One scale, both sides: full bar = 59%
× = |realized| ÷ implied
Source: market data
BIOA
BioAge Labs, Inc.
Change
5.75
▼
−2.13%
Mkt cap
$263.2M
Revenue
$2M
Q2 FY26
Revenue
$9M
FY25
DRUG
Bright Minds Biosciences Inc.
Change
23.91
▼
−56.50%
Regular session
Nov 2 '26
Mkt cap
$419.8M
Revenue
—
Revenue
—
vs
Compare
Regular session
Nov 2 '26
BIOA
BioAge Labs, Inc.
vs
DRUG
Bright Minds Biosciences Inc.
5.75
▼
−2.13%
Price
23.91
▼
−56.50%
$263.2M
Mkt cap
$419.8M
Q2 FY26
$2M
Revenue
—
FY25
$9M
Revenue
—
Change
Change
BIOA
5.75
▼
−2.13%
vs
DRUG
23.91
▼
−56.50%
Regular session
Nov 2 '26